Hostname: page-component-7dd5485656-2pp2p Total loading time: 0 Render date: 2025-10-31T09:23:43.883Z Has data issue: false hasContentIssue false
  • English
  • Français

Evidence for consistent patterns between flavonoid structures and cellular activities

Published online by Cambridge University Press:  28 February 2007

F. Depeint* ,
J. M. Gee ,
G. Williamson  and
I. T. Johnson
J. M. Gee
Affiliation:
Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK
G. Williamson
Affiliation:
Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK
I. T. Johnson
Affiliation:
Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A wide variety of plant-derived compounds, including the polyphenolic flavonoids, is present in the human diet or is consumed for medicinal reasons. Epidemiological and animal studies tend to suggest a protective effect of flavonoids against cardiovascular diseases and some types of cancer. Although flavonoids have been studied for about 50 years, the cellular mechanisms involved in their biological activity are still largely unknown. Antioxidant properties of the flavonoids have been postulated as a mechanism for putative protective effect against cardiovascular disease. Nevertheless, these properties alone are not sufficient to explain the anti-carcinogenic potential of these polyphenols. The mechanisms by which the molecules interact with cells or are absorbed by them are very important for determining the intracellular concentration and distribution of the metabolites to internal organs. With the exception of the cells lining the gastrointestinal tract, all other cells in the body are only exposed to flavonoid metabolites and degradation products. No previous studies have addressed this aspect of cellular exposure, except for some methylated metabolites. Within the last decade, reports on flavonoid activities have been largely associated with enzyme inhibition and anti-proliferative activity. From our recent work on the human colon cancer cell line HT29 and comparison with published studies, structure–function relationships demonstrate that antioxidant, enzyme inhibitor or anti-proliferative activities are dependent on particular structure motifs. The present review also presents a summary of mechanistic data on a few selected compounds.

Keywords

FlavonoidsStructure–activity relationshipEnzyme inhibitor activitiesAnti-proliferative activitiesAntioxidant activities

Information

Type
Postgraduate Symposium
Information
Proceedings of the Nutrition Society , Volume 61 , Issue 1 , February 2002 , pp. 97 - 103
Copyright
Copyright © The Nutrition Society 2002

References

Achiwa, Y, Hibasami, H, Katsuzaki, H, Imai, K & Komiya, T (1997) Inhibitory effects of persimmon (Diospyros kaki) extract and related polyphenol compounds on growth of human lymphoid leukemia cells. Bioscience Biotechnology Biochem 61, 1099–1101.CrossRefGoogle ScholarPubMed
Ader, P, Wessmann, A & Wolffram, S (2000) Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radical Biology and Medicine 28, 1056–1067.Google Scholar
Agullo, G, Gamet, L, Besson, C, Demigne, C & Remesy, C (1994) Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT29 and Caco-2 cells. Cancer Letters 87, 55–63.CrossRefGoogle ScholarPubMed
Agullo, G, Gamet-Payrastre, L, Fernandez, Y, Anciaux, N, Demigne, C & Remesy, C (1996) Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells). Cancer Letters 105, 61–70.Google Scholar
Alcaraz, MJ & Ferrandiz, ML (1987) Modification of arachidonic metabolism by flavonoids. Journal of Ethnopharmacology 21, 209–229.CrossRefGoogle ScholarPubMed
Austin, CA, Patel, S, Ono, K, Nakane, H & Fisher, LM (1992) Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochemical Journal 282, 883–889.Google Scholar
Caltagirone, S, Rossi, C, Poggi, A, Ranelletti, FO, Natali, PG, Brunetti, M, Aiello, FB & Piantelli, M (2000) Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. International Journal of Cancer 87, 595–600.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
Chen, ZP, Schell, JB, Ho, CT & Chen, KY (1998) Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Letters 129, 173–179.Google Scholar
Choi, SU, Ryu, SY, Yoon, SK, Jung, NP, Park, SH, Kim, KH, Choi, EJ & Lee, CO (1999) Effects of flavonoids on the growth and cell cycle of cancer cells. Anticancer Research 19, 5229–5233.Google Scholar
Choudhury, R, Srai, SK, Debnam, E & Rice-Evans, CA (1999) Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration. Free Radical Biology and Medicine 27, 278–286.Google Scholar
Conney, AH, Lou, YR, Xie, JG, Osawa, T, Newmark, HL, Liu, Y, Chang, RL & Huang, MT (1997) Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proceedings of the Society for Experimental Biology and Medicine 216, 234–245.Google Scholar
Csokay, B, Prajda, N, Weber, G & Olah, E (1997) Molecular mechanisms in the antiproliferative action of quercetin. Life Sciences 60, 2157–2163.CrossRefGoogle ScholarPubMed
Cushman, M & Nagarathnam, D (1991) Cytotoxicities of some flavonoid analogues. Journal of Natural Products 54, 1656–1660.CrossRefGoogle ScholarPubMed
Day, AJ, Canada, FJ, Diaz, JC, Kroon, PA, McLauchlan, R, Faulds, CB, Plumb, GW, Morgan, MR & Williamson, G (2000) Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Letters 468, 166–170.CrossRefGoogle ScholarPubMed
Day, AJ, DuPont, MS, Ridley, S, Rhodes, M, Rhodes, MJ, Morgan, MR & Williamson, G (1998) Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Letters 436, 71–75.Google Scholar
Deschner, EE, Ruperto, JF, Wong, GY & Newmark, HL (1993) The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutrition and Cancer 20, 199–204.CrossRefGoogle ScholarPubMed
Galati, G, Teng, S, Moridani, MY, Chan, TS & O'Brien, PJ (2000) Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metabolism and Drug Interactions 17, 311–349.CrossRefGoogle ScholarPubMed
Gee, JM, DuPont, MS, Day, AJ, Plumb, GW, Williamson, G & Johnson, IT (2000) Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. Journal of Nutrition 130, 2765–2771.CrossRefGoogle ScholarPubMed
Gee, JM, DuPont, MS, Rhodes, MJ & Johnson, IT (1998) Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radical Biology and Medicine 25, 19–25.Google Scholar
Goldbohm, RA, van't Veer, P, van den Brandt, PA, van't Hof, MA, Brants, HA, Sturmans, F & Hermus, RJ (1995) Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. European Journal of Clinical Nutrition 49, 420–429.Google ScholarPubMed
Harborne, JB & Williams, CA (2000) Advances in flavonoid research since 1992. Phytochemistry 55, 481–504.Google Scholar
Hayashi, A, Gillen, AC & Lott, JR (2000) Effects of daily oral administration of quercetin chalcone and modified citrus pectin. Alternative Medicine Review 5, 546–552.Google ScholarPubMed
Haza, AI, Glinghammar, B, Grandien, A & Rafter, J (2000) Effect of colonic luminal components on induction of apoptosis in human colonic cell lines. Nutrition and Cancer 36, 79–89.CrossRefGoogle ScholarPubMed
Hertog, MG & Hollman, PC (1996) Potential health effects of the dietary flavonol quercetin. European Journal of Clinical Nutrition 50, 63–71.Google ScholarPubMed
Hertog, MG, Kromhout, D, Aravanis, C, Blackburn, H, Buzina, R, Fidanza, F et al. (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Archives of Internal Medicine 155, 381–386.Google Scholar
Hollman, PC & Katan, MB (1999) Dietary flavonoids: intake, health effects and bioavailability. Food Chemistry and Toxicology 37, 937–942.Google Scholar
Kamei, H, Kojimo, T, Koide, T, Hasegawa, M, Umeda, T, Teraba, K & Hashimoto, Y (1996) Influence of OH group and sugar bonded to flavonoids on flavonoid-mediated suppression of tumor growth in vitro. Cancer Biotherapy and Radiopharmacology 11, 247–249.CrossRefGoogle ScholarPubMed
Kang, TB & Liang, NC (1997) Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochemical Pharmacology 54, 1013–1018.Google Scholar
Kawaii, S, Tomono, Y, Katase, E, Ogawa, K & Yano, M (1999) Antiproliferative activity of flavonoids on several cancer cell lines. Bioscience, Biotechnology and Biochemistry 63, 896–899.Google Scholar
Knekt, P, Jarvinen, R, Seppanen, R, Hellovaara, M, Teppo, L, Pukkala, E & Aromaa, A (1997) Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. American Journal of Epidemiology 146, 223–230.Google Scholar
Kong, AN, Yu, R, Chen, C, Mandlekar, S & Primiano, T (2000) Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Archives of Pharmacal Research 23, 1–16.CrossRefGoogle ScholarPubMed
Kuhnau, J (1976) The flavonoids. A class of semi-essential food components: their role in human nutrition. World Review of Nutrition and Dietetics 24, 117–191.Google Scholar
Kuntz, S, Wenzel, U & Daniel, H (1999) Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. European Journal of Nutrition 38, 133–142.Google Scholar
Kuo, SM (1998) Transepithelial transport and accumulation of flavone in human intestinal Caco-2 cells. Life Sciences 63, 2323–2331.CrossRefGoogle ScholarPubMed
Kuo, SM, Morehouse, HF Jr & Lin, CP (1997) Effect of antiproliferative flavonoids on ascorbic acid accumulation in human colon adenocarcinoma cells. Cancer Letters 116, 131–137.CrossRefGoogle ScholarPubMed
Mahmoud, NN, Carothers, AM, Grunberger, D, Bilinski, RT, Churchill, MR, Martucci, C, Newmark, HL & Bertagnolli, MM (2000) Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21, 921–927.CrossRefGoogle Scholar
Manach, C, Morand, C, Demigne, C, Texier, O, Regerat, F & Remesy, C (1997) Bioavailability of rutin and quercetin in rats. FEBS Letters 409, 12–16.CrossRefGoogle ScholarPubMed
Mutoh, M, Takahashi, M, Fukuda, K, Komatsu, H, Enya, T, Matsushima-Hibiya, Y, Mutoh, H, Sugimura, T & Wakabayashi, K (2000 a) Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship. Japanese Journal of Cancer Research 91, 686–691.Google Scholar
Mutoh, M, Takahashi, M, Fukuda, K, Matsushima-Hibiya, Y, Mutoh, H, Sugimura, T & Wakabayashi, K (2000 b) Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 21, 959–963.Google Scholar
Pforte, H, Hempel, J & Jacobasch, G (1999) Distribution pattern of a flavonoid extract in the gastrointestinal lumen and wall of rats. Nahrung 43, 205–208.3.0.CO;2-M>CrossRefGoogle ScholarPubMed
Ranelletti, FO, Maggiano, N, Serra, FG, Ricci, R, Larocca, LM, Lanza, P, Scambia, G, Fattorossi, A, Capelli, A & Piantelli, M (2000) Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors. International Journal of Cancer 85, 438–445.Google Scholar
Rice-Evans, CA, Miller, NJ & Paganga, G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine 20, 933–956.Google Scholar
Richter, M, Ebermann, R & Marian, B (1999) Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutrition and Cancer 34, 88–99.CrossRefGoogle ScholarPubMed
Russo, M, Palumbo, R, Tedesco, I, Mazzarella, G, Russo, P, Iacomino, G & Russo, GL (1999) Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line. FEBS Letters 462, 322–328.CrossRefGoogle ScholarPubMed
Scalbert, A & Williamson, G (2000) Dietary intake and bioavailability of polyphenols. Journal of Nutrition 130, 2073S–2085S.CrossRefGoogle ScholarPubMed
Shimizu, K, Kondo, R & Sakai, K (2000) Inhibition of tyrosinase by flavonoids, stilbenes and related 4-substituted resorcinols: structure-activity investigations. Planta Medica 66, 11–15.CrossRefGoogle ScholarPubMed
Skibola, CF & Smith, MT (2000) Potential health impacts of excessive flavonoid intake. Free Radical Biology and Medicine 29, 375–383.Google Scholar
Spencer, JP, Chowrimootoo, G, Choudhury, R, Debnam, ES, Srai, SK & Rice-Evans, C (1999) The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Letters 458, 224–230.CrossRefGoogle ScholarPubMed
Thompson, MA, Rosenthal, MA, Ellis, SL, Friend, AJ, Zorbas, MI, Whitehead, RH & Ramsay, RG (1998) c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression. Cancer Research 58, 5168–5175.Google Scholar
Umarova, FT, Khushbactova, ZA, Batirov, EH & Mekler, VM (1998) Inhibition of Na+, K(+)-ATPase by flavonoids and their inotropic effect. Investigation of the structure-activity relationship. Membrane and Cell Biology 12, 27–40.Google Scholar
Walgren, RA, Lin, JT, Kinne, RK & Walle, T (2000) Cellular uptake of dietary flavonoid quercetin 4>-beta-glucoside by sodium-dependent glucose transporter SGLT1. Journal of Pharmacology and Experimental Therapeutics 294, 837–843.Google Scholar
Walle, T, Otake, Y, Walle, UK & Wilson, FA (2000) Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. Journal of Nutrition 130, 2658–2661.CrossRefGoogle ScholarPubMed
Walle, T, Otake, Y, Brubaker, JA, Walle, UK & Halushka, PV (2001) Disposition and metabolism of the flavonoid chrysin in normal volunteers. British Journal of Clinical Pharmacology 51, 143–146.Google Scholar
Walle, UK, French, KL, Walgren, RA & Walle, T (1999) Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2. Research Communications in Molecular Pathology and Pharmacology 103, 45–56.Google ScholarPubMed
Wang, HK (2000) The therapeutic potential of flavonoids. Expert Opinion on Investigational Drugs 9, 2103–2119.CrossRefGoogle ScholarPubMed
Wattenberg, LW (1985) Chemoprevention of cancer. Cancer Research 45, 1–8.Google ScholarPubMed
Wheeler, EL & Berry, DL (1986) In vitro inhibition of mouse epidermal cell lipoxygenase by flavonoids: structure-activity relationships. Carcinogenesis 7, 33–36.CrossRefGoogle ScholarPubMed
Williamson, G, Day, AJ, Plumb, GW & Couteau, D (2000) Human metabolic pathways of dietary flavonoids and cinnamates. Biochemical Society Transactions 28, 16–22.Google Scholar
Yoshida, M, Sakai, T, Hosokawa, N, Marui, N, Matsumoto, K, Fujioka, A, Nishino, H & Aoike, A (1990) The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Letters 260, 10–13.Google Scholar